Oesophageal cancer is the eighth most common cause of cancer death worldwide ([@bib12]). Gastric atrophy as a consequence of chronic *Helicobacter pylori* infection was linked to an increased risk of oesophageal squamous cell carcinoma (OSCC) in a Swedish population-based case--control study ([@bib30]). In the atrophic stomach, hypochlorohydria allows bacterial overgrowth ([@bib29]) and may produce potential carcinogenic substances, such as nitrosamines, which are also related to alcohol drinking and tobacco smoking ([@bib19]). Histology is the gold standard for diagnosing gastric atrophy. However, because of its inconvenience in large epidemiological studies, serum level of pepsinogens has been applied as a replacement method. Pepsinogen I (PGI) is produced in the fundic glands and decreases proportionally with progression of fundic atrophy. Pepsinogen II (PGII) is synthesised in most parts of the gastric mucosa and part of the duodenum and some studies have shown its importance in detecting inflammation ([@bib9]) or gastric cancer screening ([@bib3]). Magnitude of the reported associations between serological gastric atrophy and OSCC varied from null to eightfold ([@bib10]; [@bib8]; [@bib26]; [@bib7]; [@bib28]).

Poor oral and dental hygiene are also linked to nitrosamine ([@bib18]) and acetaldehyde production([@bib23]). In addition, poor oral hygiene and dental health have been shown to be associated with an increased risk of OSCC in high-risk areas ([@bib2], [@bib1]). Previous studies have not tested possible synergism between these two risk factors. Golestan province in Iran is located in the Asian Oesophageal Cancer Belt and has some of the highest incidence rates for OSCC ([@bib15]; [@bib27]). Unlike low-risk areas, tobacco and alcohol use are not major risk factors for OSCC in this belt ([@bib22]), from which 90% of the OSCC cases arise worldwide. We evaluated the association between gastric atrophy (measured by serum pepsinogen level) and OSCC in a population-based case--control study in Northern Iran and tested joint effect on OSCC risk in the presence of both gastric atrophy and poor oral hygiene.

Materials and methods
=====================

Case and control selection
--------------------------

Details of subject selection have been reported earlier ([@bib22]). Briefly, case subjects were recruited at Atrak clinic, the only specialised clinic for oesophageal cancer diagnosis and treatment in eastern Golestan, from December 2003 to June 2007. Included cases were those of histopathologically confirmed OSCC patients who underwent oesophago-gastro-duodenal videoscopy at Atrak clinic and agreed to participate in the study. The reports of the local cancer registry demonstrated that ∼70% of all incident cases during the study period were referred to Atrak clinic (unpublished data). Attempts were made to select two population-based control subjects, individually matched to the cases by age (±2 years), sex, and from the same neighbourhood or village using annually updated family health census. List of all potentially eligible controls for rural cases was ordered randomly in each village and for urban cases was ordered by geographic proximity to the case\'s residence. In all, 77% of the enrolled controls were the first selected neighbours, and 11% and 3%, respectively, were the second and third choices from the lists. Absence of the eligible control at the time of invitation was almost always the reason for not participating in the study. In total, we recruited 300 cases and 571 matched controls.

To investigate whether OSCC cases have higher risk of developing non-atrophic gastritis in histology, we used another set of controls. Controls were consisted of endoscopy room patients who were referred to Atrak clinic with a suspicion of upper gastrointestinal malignancies during same period of case enrolment and were matched for age and sex. Three biopsy tissues from lesser-curvature antrum, lesser-curvature body and cardia were available for 261 cases (88%) and 274 controls.

Interview and examination
-------------------------

After obtaining written informed consent from each subject, a nurse and a physician administered a structured questionnaire. A nutritionist administered a validated food frequency questionnaire ([@bib16]). All interviews were conducted face to face at Atrak clinic for case subjects and at health centres for controls except those chosen from Gonbad city who were interviewed at Golestan Cohort Centre. No proxies were used.

The trained physicians examined each patient\'s oral cavity and teeth. Number of decayed, missing, and filled teeth (DMFT score) in addition to frequency of tooth brushing was recorded. Detailed information has been published elsewhere ([@bib1]). Reliability of measuring tooth count using κ statistic was 0.86 ([@bib25]). Data was collected on demographic variables, ethnicity, alcohol consumption, lifelong history of tobacco or opium use, medication, and several potential confounders.

Serological data
----------------

Prior to endoscopy, an experienced nurse collected 12 ml venous blood sample from each case subject. A trained technician immediately separated serum and stored it at −80 °C. Collected blood samples from matched controls were transferred on ice in a cooler box (∼4 °C). Time between collection and processing of neighbourhood control samples was \<12 h. For those controls who were interviewed at the Golestan Cohort Centre, sample processing and storage were performed immediately. Samples were transported on dry ice to Karolinska Institutet, Sweden, and stored at −20 °C prior to analysis. Serum pepsinogen I and II were measured blinded to case--control status using enzyme-linked immunosorbent assays (Biohit, Helsinki, Finland). Aliquots from a pool of serum samples of healthy individuals were distributed among nine assay plates (two samples per plate). The coefficients of variation were 8% and 14% for PGI and PGII, respectively. *H. pylori* serology was evaluated qualitatively with western blot assay (Helico Blot 2.1; MP Biomedicals Asia Pacific Ltd, Singapore, Singapore). *H. pylori* infection was considered positive if (1) both 19.5- and 30-kDa bands were present or (2) any of the 35-, 37-, or 89-kDa band was present. CagA was positive if 116-kDa band was present. We have carried out a validation study in the same population with similar ethnic structure among 309 endoscopy clinic patients and compared pepsinogen serology with histology using modified Sydney classification as the gold standard. We reported PGI\<55 *μ*g l^−1^ (sensitivity: 61.9%, specificity: 94.8%) as the optimal cutoff point for serological diagnosis of gastric fundal atrophy in the study population. At cutoff concentration of 11.8 *μ*g l^−1^, PGII demonstrated 84.2% sensitivity and 45.4% specificity to distinguish nonatrophic pangastritis ([@bib21]).

Statistical methods
-------------------

Serum PGI and PGII were analysed as dichotomous variables using validated cutoff points. There was no *a priori* DMFT cutoff value, and cubic spline curve did not highlight any specific pattern, therefore the median DMFT was considered as a cutoff value for dichotomising it. Conditional logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). In design, case and control subjects were individually matched for age, sex, and place of residence. ORs were further adjusted for education, ethnicity (Turkmen *vs* non-Turkmen), tobacco and opium use, alcohol drinking, and fruit/vegetable consumption. Interaction on additive scale between dichotomous variables of gastric atrophy and poor dental health or oral hygiene habit was evaluated and the relative excess risk due to interaction (RERI), attributable proportion and synergy index were calculated. Delta method was applied to calculate 95% CI for measures of interaction. To address the effect of bias due to measurement error in serology assay, the ORs adjusted for misclassification as a function of different sensitivity and specificity for cases and controls were calculated using external validation data. Two-sided *P*-values ⩽0.05 were considered as statistically significant. All analyses were done using Stata version 11.1 (StataCorp., College Station, TX, USA).

Ethical approval
----------------

This study was approved by the ethical committee of the Digestive Disease Research Centre of Tehran University of Medical Sciences, Iran, the Institutional Review Board of National Cancer Institute, USA, and the Stockholm Regional Ethics Vetting Board, Sweden.

Results
=======

The study included 300 incident case patients and 571 matched control subjects from whom serum samples were available for 293 (98%) cases and 524 (92%) controls. All cases had at least one matched control. Demographic characteristics of the study participants and potential confounders are summarised in [Table 1](#tbl1){ref-type="table"}. No substantial differences were observed between those who provided serum and those whose serum samples were not available.

[Table 2](#tbl2){ref-type="table"} demonstrates proportion of subjects with serological gastric atrophy and ORs for association of PGI and PGII with OSCC risk after further controlling for education level and ethnicity (as socioeconomic index), opium and tobacco use, fruit, vegetable, and alcohol consumption. A PGI \<55 *μ*g l^−1^ was associated with a 1.39-fold increased risk of OSCC (95% CI: 0.93, 2.09). Histological diagnosis of non-atrophic gastritis was found in 30% of OSCC cases with 2-fold risk comparing clinic controls (OR=1.97, 95% CI: 1.13, 3.45) ([Supplementary Table](#sup1){ref-type="supplementary-material"}). Because gastritis might be caused secondary to OSCC, we evaluated the association of gastric fundal atrophy with OSCC in combination with severe nonatrophic pangastritis. Combination of PGI \<55 *μ*g l^−1^ and PGII \<11.8 *μ*g l^−1^ was associated with a two-fold increased risk for OSCC. Further adjustment for tea-drinking habit as a suggested strong risk factor in this population ([@bib11]) did not alter the observed estimates. *H. pylori* serology, measured as antibodies against either whole *H. pylori* or CagA, was not associated with OSCC risk.

We applied other published thresholds for atrophy, including PGI \<30 *μ*g l^−1^, PGI/PGII ratio \<3 and PGI \<70 *μ*g l^−1^, PGI/PGII ratio \<3. The measures of association did not change materially. Combination with PGII also showed similar results ([Table 3](#tbl3){ref-type="table"}).

[Table 4](#tbl4){ref-type="table"} presents the results of joint effect of gastric atrophy, poor dental health, and oral hygiene habit on OSCC risk after breaking the matching factors. Adjusted OR for association of DMFT with OSCC was 1.60 (95% CI: 1.14, 2.24). Although based on modest numbers of cases, presence of poor dental hygiene, indicated as higher than median DMFT, and gastric atrophy rendered a more than four-fold excess risk of OSCC compared with the group with neither poor dental hygiene nor atrophy. The RERI between low DMFT and atrophy was 1.47 (95% CI: −1.15, 4.1), synergy index (95% CI) 1.90 (0.6, 6.1), and the attributable proportion (95% CI) 0.36 (−0.14, 0.85). We used frequency of tooth brushing as another measure of dental and oral hygiene in combination with gastric atrophy, which resulted in an eight-fold increase in OSCC risk (OR: 8.65, 95% CI: 3.65, 20.46) compared with non-atrophic group who occasionally or regularly brush their teeth. The RERI between habit of never brushing teeth and atrophy was 4.34 (95% CI: −1.07, 9.76), synergy index 2.24 (95% CI: 0.97, 5.15), and attributable proportion 0.49 (95% CI: 0.14, 0.83). Although based on fewer sets, conditional logistic regression model showed similar results (data not shown).

To quantify the magnitude of misclassification bias that occurs in presence of nonatrophic gastritis, we estimated the classification probabilities using external validation study ([@bib21]). Effects of the range of PGII levels on diagnostic accuracy of atrophy and corrected ORs for the association with OSCC are presented in [Table 5](#tbl5){ref-type="table"}. Differential misclassification of gastric atrophy for cut points with low specificity (\<80%) was far from the null. When exposure detection was better among controls, the resulted OR was extensively biased.

Discussion
==========

In this study, gastric atrophy, as indicated by low serum pepsinogen, was associated with an increased risk of OSCC.

Pepsinogens are markers of mixed conditions, including gastritis and atrophy ([@bib9]), which could be of distinct etiologies in cancer patients. In spite of observed association between serological nonatrophic pangastritis with OSCC in our study, the probability of developing gastritis secondary to oesophageal cancer is not ignorable because of several evidences. Most importantly, studies with cohort design did not detect significant association between PGII and OSCC risk. In addition, cancer patients may develop gastritis due to non-steroidal anti-inflammatory drug (NSAID) use, opportunistic infections in stomach (cytomegalovirus, Epstein--Barr virus), malnutrition, anaemia, and consequent use of iron tablets ([@bib4]; [@bib14]). Stage of tumours in most of our study population were III or IV at the time of diagnosis, and dysphagia was the presenting symptom, which led to high proportion of NSAID consumption among cases compared with controls (24.7% *vs* 15.8%, *P*=0.001). On the other hand, development of marked atrophy needs long time period ([@bib5]) and its initiation during OSCC progression with short lead time is unlikely. Thus, in studying the relationship between gastric atrophy and OSCC when serum collection period is close to cancer diagnosis, PGI provides more valid estimate than PGI/PGII ratio.

Low sensitivity for atrophy detection might lead to loss of precision and power by unnecessarily reducing the exposed sample size. We chose atrophy cutoff point at high specificity level (97%) however, false negative probability of 0.4 and low prevalence of gastric atrophy could potentially result in misclassification of exposure among cases and controls. Which we believe, if evolves, would be differential.

Histology is the gold standard for atrophy diagnosis, however, detection of atrophy is difficult because of the limitation in number of biopsies and patchy nature of atrophy. Furthermore, mucosal inflammation and separation of glands by inflammatory infiltrate would add more diagnostic difficulties in severe gastritis ([@bib24]). Because inflammation among our cancer patients was more probable than healthy controls, the error probabilities for unexposed cases and controls might not be identical. To decrease the effect of mixed category and to reduce the problem of non-identical false-negative probabilities, we stratified the presence of nonatrophic pangastritis and observed a two-fold increased OSCC risk associated with atrophy.

Notably, reducing interpretations to a dichotomy could degrade the information. False-negative results are inherent in serological diagnosis of atrophy due to the low sensitivity of the diagnostic method. It is believed that resulted misclassification will drive the association toward null if non-differential assumptions are met. However, atrophy is an uncommon exposure and its binary value is the result of categorising continuous PGI variable. Therefore, we performed a sensitivity analysis with the external validation data. Our results confirmed that the effect of misclassification due to ignoring nonatrophic pangastritis on association between atrophy and OSCC was substantial. This finding suggests that PGII as a marker of severe inflammation could be used as a stratifying factor.

In this study, we could not detect any association between infection with *cagA*-positive *H. pylori* strains and OSCC risk, which is in contrast to the results from the study among low-risk Swedish population ([@bib30]), Japanese alcoholic males ([@bib31]), and in accordance to the reports from studies in Linxian of China ([@bib13]), Magdeburg of Germany ([@bib28]), and among Finnish male smokers ([@bib7]). Spontaneous disappearance of *H. pylori* over time or *H. pylori* eradication is possibly common in endemic areas. Acquired immunodeficiency among advanced malnourished cancer patients could be another explanation for reduced immune response to antigens. These possibilities could lead to heterogeneity of *H. pylori*-negative category as a reference. Hence, our risk estimates for *H. pylori* and CagA infection are inconclusive because of difficulties in achieving a clean reference group in an endemic area for *H. pylori* infection and among aged population in a case--control design.

Our study might indicate areas to search for the underlying mechanism. There was a suggestive evidence that the estimated joint effect of poor dental health or never tooth brushing and gastric atrophy together was larger than the sum of their effects alone, which is in favour of the hypothesis of the bacterial overgrowth in atrophic stomach and low-hygiene periodontal mucosa ([@bib17]). Endogenous formation of nitrosamines in the oral cavity of those with poor oral hygiene is eightfold higher than that in those with good oral hygiene ([@bib20]). Upstream microbial community members from the oral mucosa and oesophagus have the potential to translocate to the stomach, and they might act as reservoirs for recolonisation. Gastric microbiota shows considerable overlap with oral microbiota ([@bib6]), however, the mechanism of these two bacterial environment in OSCC carcinogenesis could be different. Our statistical inference on the presence of interaction between poor oral hygiene and gastric atrophy has less precision than the main finding of the study because of the modest sample size. The observed interaction might be due to other mechanisms, as tooth loss may be an indicator of a less healthy life style. However, we did not detect association between education as a socioeconomic status indicator and DMFT in our data. Also, low DMFT could be a marker for distinct diet because of reduced masticatory ability, hence, the detected association might be due to residual confounding.

This study was a population-based study, matching improved statistical efficiency, and sample size was the largest among the studies so far published. Markers of the main exposure and confounders were validated and extensive information on cofounders was available.

In conclusion, our population-based case--control study confirms that gastric atrophy is a risk factor for OSCC in high-risk area of northern Iran. Excluding nonatrophic pangastritis through stratifying by PGII level decreases the possibility of PGI misclassification due to cancer-induced inflammation. Gastric atrophy and poor oral hygiene may act synergistically in increasing the risk of OSCC.
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###### Characteristics of OSCC cases and matched controls, Golestan province, Iran, 2003--2007

  **Characteristics**                                        **Cases (*****n*****=293)**   **Controls (*****n*****=524)**   ***P*****-value**   **Controls without serum samples (*****n*****=47)**   ***P*****-value**[a](#t1-fn2){ref-type="fn"}
  ---------------------------------------------------------- ----------------------------- -------------------------------- ------------------- ----------------------------------------------------- ----------------------------------------------
  Mean age (s.d.), years                                     64.4 (11.1)                   65.5 (10.4)                      0.95                62.1 (9.9)                                            0.07
  *Sex (%)*                                                                                                                                                                                           
   Men                                                       147 (50.2)                    256 (48.8)                       0.71                22 (46.8)                                             0.8
   Women                                                     146 (49.8)                    268 (51.2)                                           25 (53.2)                                              
                                                                                                                                                                                                       
  *Residence area (%)*                                                                                                                                                                                
   Urban                                                     80 (27.3)                     133 (25.4)                       0.54                17 (36.2)                                             0.1
   Rural                                                     213 (72.7)                    391 (74.6)                                           30 (63.8)                                              
                                                                                                                                                                                                       
  *Ethnicity (%)*                                                                                                                                                                                     
   Turkmen                                                   166 (56.7)                    282 (53.8)                       0.43                30 (63.8)                                             0.18
   Non-Turkmen                                               127 (43.3)                    242 (46.2)                                           17 (36.2)                                              
                                                                                                                                                                                                       
  *Education (%)*                                                                                                                                                                                     
   Illiterate                                                261 (89.1)                    437 (83.4)                       0.02                37 (87.7)                                             0.41
   Primary school and higher                                 32 (10.9)                     87 (16.6)                                            10 (21.3)                                              
                                                                                                                                                                                                       
  *Alcohol ever use (%)*                                                                                                                                                                              
   No                                                        287 (98)                      511 (97.5)                       0.69                46 (97.9)                                             0.88
   Yes                                                       6 (2)                         13 (2.5)                                             1 (2.1)                                                
                                                                                                                                                                                                       
  *Tobacco and opium use*[b](#t1-fn3){ref-type="fn"} *(%)*                                                                                                                                            
   Neither                                                   162 (55.5)                    366 (70.0)                       0.0002              32 (68.1)                                             0.58
   Ever use tobacco                                          43 (14.7)                     59 (11.3)                                            7 (14.9)                                               
   Ever use opium                                            29 (10.0)                     33 (6.3)                                             1 (2.1)                                                
   Ever use tobacco and opium                                58 (19.8)                     65 (12.4)                                            7 (14.9)                                               
                                                                                                                                                                                                       
  *Fruit and vegetable consumption (%)*                                                                                                                                                               
   ⩽ Median[c](#t1-fn4){ref-type="fn"}                       139 (47.4)                    235 (44.8)                       0.47                20 (42.5)                                             0.76
   \> Median                                                 154 (52.6)                    289 (55.1)                                           27 (57.5)                                              
                                                                                                                                                                                                       
  *DMFT (%)*[b](#t1-fn3){ref-type="fn"}                                                                                                                                                               
   ⩽ Median (28)                                             117 (40.3)                    266 (51.0)                       0.004               28 (59.6)                                             0.25
   \> Median                                                 173 (59.7)                    256 (49.0)                                           19 (40.4)                                              
                                                                                                                                                                                                       
  *Tooth brushing habit*[b](#t1-fn3){ref-type="fn"}                                                                                                                                                   
   Ever                                                      59 (20.3)                     221 (42.4)                       \<0.0001            18 (39.1)                                             0.66
   Never                                                     232 (79.7)                    300 (57.6)                                           28 (60.9)                                              
                                                                                                                                                                                                       
  PGI (*μ*g l^−1^), median (IQR)                             109.3 (67.2--147.5)           94.9 (66.6--123.3)                                   NA                                                     
  PGII (*μ*g l^−1^), median (IQR)                            14.2 (9.6--21.5)              12.3 (8.8--18.2)                                     NA                                                     
  PGI/PGII ratio, median (IQR)                               7.0 (4.8--9.7)                7.2 (5.3--9.9)                                       NA                                                     

Abbreviations: DMFT=Sum of decayed, missed, and filled teeth; IQR=interquartile range; NA=not applicable; OSCC=oesophageal squamous cell carcinoma.

*P*-value for significance of difference between controls with and without serum samples.

Numbers of cases and controls were less than total because of missed data.

Median fruit and vegetable consumption=521.8 gr/day.

###### Levels of pepsinogen I, pepsinogen II, and *H. pylori* serology and their associations with OSCC risk, Golestan province, Iran, 2003--2007

                                                             **Controls,** ***N*** **(%)**   **Cases,** ***N*** **(%)**   **Crude OR (95% CI)**   **Adjusted OR (95% CI)**[a](#t2-fn2){ref-type="fn"}
  ---------------------------------------------------------- ------------------------------- ---------------------------- ----------------------- -----------------------------------------------------
  *PGI (μg l*^*−1*^)                                                                                                                              
   ⩾ 55                                                      449 (85.7)                      238 (81.2)                   Referent                Referent
   \< 55                                                     75 (14.3)                       55 (18.8)                    1.33 (0.89--1.97)       1.39 (0.93--2.09)
                                                                                                                                                   
  *PGII*[b](#t2-fn3){ref-type="fn"} *(μg l*^*−1*^)                                                                                                
   \<11.8                                                    246 (46.9)                      113 (38.7)                   Referent                Referent
   ⩾ 11.8                                                    278 (53.1)                      179 (63.1)                   1.37 (1.01--1.85)       1.40 (1.01--1.92)
                                                                                                                                                   
  *PGI and PGII*[b](#t2-fn3){ref-type="fn"} *(μg l*^*−1*^)                                                                                        
   PGI ⩾55 and PGII\<11.8                                    189 (36.1)                      71 (24.2)                    Referent                Referent
   PGI \<55 and PGII \<11.8                                  57 (10.9)                       42 (14.3)                    1.92 (1.15--3.22)       2.01 (1.18--3.45)
   PGI ⩾55 and PGII ⩾11.8                                    260 (49.6)                      167 (57)                     Referent                Referent
   PGI\<55 and PGII ⩾11.8                                    18 (3.4)                        12 (4.4)                     1.02 (0.47--2.23)       1.20 (0.54--2.66)
                                                                                                                                                   
  *H. pylori status*                                                                                                                              
   *H. pylori*− cagA−                                        52 (10)                         35 (12)                      Referent                Referent
   *H. pylori*+ cagA−                                        34 (6.5)                        14 (4.8)                     0.64 (0.30--1.35)       0.70 (0.32--1.53)
   *H. pylori*+ cagA+                                        351 (67.2)                      179 (61.3)                   0.73 (0.46--1.17)       0.79 (0.48--1.29)
   *H. pylori*− cagA+                                        85 (16.3)                       64 (21.9)                    1.05 (0.60--1.85)       1.15 (0.63--2.08)

Abbreviations: cagA=cytotoxin-associated gene A; CI=confidence interval; *H. pylori=Helicobacter pylori*; OR=odds ratio; OSCC=oesophageal squamous cell carcinoma; PGI=pepsinogen I; PGII=pepsinogen II.

Adjusted for ethnicity (Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or more), and vegetable/fruit consumption.

For one case, PGII level was missing and just PGI level was available.

###### Gastric atrophy defined by other serology criteria in literature and its association with OSCC risk

                                                           **Controls,** ***N*** **(%)**   **Cases,** ***N*** **(%)**   **Adjusted OR (95% CI)**[a](#t3-fn2){ref-type="fn"}
  -------------------------------------------------------- ------------------------------- ---------------------------- -----------------------------------------------------
  *PGI*                                                                                                                 
   PGI ⩾30                                                 500 (95.4)                      274 (93.5)                   Referent
   PGI \<30                                                24 (4.6)                        19 (6.5)                     1.52 (0.79--2.93)
                                                                                                                         
  *Stratifying by PGII level*[b](#t3-fn3){ref-type="fn"}                                                                
   PGI ⩾30 and PGII\<11.8                                  226 (43.1)                      97 (33.1)                    Referent
   PGI \<30 and PGII \<11.8                                4 (0.8)                         3 (1.0)                      1.94 (0.91--4.13)
   PGI ⩾30 and PGII ⩾11.8                                  274 (52.3)                      176 (60.4)                   Referent
   PGI \<30 and PGII ⩾11.8                                 20 (3.8)                        16 (5.5)                     1.10 (0.23--5.17)
                                                                                                                         
  *PGI/PGII ratio*[b](#t3-fn3){ref-type="fn"}                                                                           
   Ratio ⩾3                                                490 (93.5)                      265 (90.8)                   Referent
   Ratio \<3                                               34 (6.5)                        27 (9.2)                     1.50 (0.85--2.60)
                                                                                                                         
  *Stratifying by PGII level*[b](#t3-fn3){ref-type="fn"}                                                                
   Ratio ⩾3 and PGII \<11.8                                233 (44.5)                      100 (34.1)                   Referent
   Ratio \<3 and PGII \<11.8                               21 (4.0)                        14 (4.8)                     2.32 (1.00--5.39)
   Ratio ⩾3 and PGII ⩾11.8                                 257 (49.0)                      165 (56.7)                   Referent
   Ratio\<30 and PGII ⩾11.8                                13 (2.5)                        13 (4.4)                     1.03 (0.49--2.20)
                                                                                                                         
  *PGI and PGI/PGII ratio*[b](#t3-fn3){ref-type="fn"}                                                                   
   PGI ⩾70 or ratio ⩾3                                     497 (94.9)                      267 (91.5)                   Referent
   PGI \<70 and ratio \<3                                  27 (5.1)                        25 (8.5)                     1.69 (0.93--3.10)
                                                                                                                         
  *Stratifying by PGII level*[b](#t3-fn3){ref-type="fn"}                                                                
   (PGI ⩾70 or ratio ⩾3) and PGII \<11.8                   233 (44.5)                      100 (34.19)                  Referent
   (PGI \<70 and ratio \<3) and PGII \<11.8                14 (2.6)                        12 (4.1)                     2.31 (0.99--5.38)
   (PGI ⩾70 or ratio ⩾3) and PGII ⩾11.8                    264 (50.4)                      167 (57.4)                   Referent
   (PGI \<70 and ratio \<3) and PGII ⩾11.8                 13 (2.5)                        13 (4.4)                     1.24 (0.52--2.94)

Abbreviations: CI=confidence interval; OR=odds ratio; OSCC=oesophageal squamous cell carcinoma; PGI=pepsinogen I; PGII=pepsinogen II.

Adjusted for ethnicity (Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or more), and vegetable/fruit consumption.

For one case, PGII level was missing and just PGI level was available.

###### Combined effects of gastric atrophy and dental health or oral hygiene habit on OSCC risk after breaking the matching factors

                          **Gastric atrophy −**   **Gastric atrophy +**          
  ---------------------- ----------------------- ----------------------- ------- --------------------
  DMFT ⩽28                       29/104                 Referent          12/26  1.65 (0.74--3.67)
                                                                                 *P*=0.20
  DMFT \>28                       40/84             1.71 (0.98--2.98)     30/31  3.47 (1.81--6.64)
                                                        *P*=0.06                 *P* \<0.001
  Ever tooth brushing             14/87                 Referent          5/24   1.40 (0.44--4.39)
                                                                                 *P*=0.57
  Never tooth brushing           57/100             4.12 (2.05--8.28)     37/33  8.77 (3.89--19.72)
                                                       *P* \<0.001               *P* \<0.001

Abbreviations: CI=confidence interval; DMFT=sum of decayed, missed, and filled teeth; OR=odds ratio; OSCC=oesophageal squamous cell carcinoma.

Measure of interaction on additive scale: relative excess risk due to interaction with low DMFT (95% CI): 1.47 (−1.15 to 4.1) and with never tooth brushing habit (95% CI): 4.34 (−1.07 to 9.76).

Measure of interaction on multiplicative scale: between atrophy and low DMFT: OR (95% CI): 1.44 (0.63--3.32); *P*=0.39 and measure of interaction between atrophy and never tooth brushing on multiplicative scale: OR (95% CI): 1.78 (0.30--10.42); *P*=0.52.

ORs (95% CI) levels adjusted for age, sex, residence area, ethnicity (Non-Turkmen or Turkmen), alcohol consumption (never or ever), tobacco or opium use (none, only tobacco, only opium, or both), education level (illiterate, primary school or more), and vegetable/fruit consumption.

###### Gastric atrophy defined by PGI \<55 *μ*g l^−1^ and its association with OSCC risk under assumption of various sensitivity (se) and specificity (sp) among cases and controls

                                       **Controls All PGII**           **Only PGII \<5**           **Only PGII \<11.8**           **Only PGII \<15**            **Only PGII \<19**            **Only PGII \<30**           **Only PGII \>11.8**
  ------------------ ------ ------ ----------------------------- ----------------------------- ----------------------------- ----------------------------- ----------------------------- ----------------------------- -----------------------------
  All PGII            0.62   0.95              1.63               [a](#t5-fn3){ref-type="fn"}               6.6                           3.9                           3.3                           2.4                          0.59
  Only PGII \<5       0.99   0.68   [a](#t5-fn3){ref-type="fn"}              0.79               [a](#t5-fn3){ref-type="fn"}   [a](#t5-fn3){ref-type="fn"}   [a](#t5-fn3){ref-type="fn"}   [a](#t5-fn3){ref-type="fn"}   [a](#t5-fn3){ref-type="fn"}
  Only PGII \<11.8    0.83   0.89               0.6               a[](#t5-fn1){ref-type="fn"}               2.5                           1.5                           1.3                           0.9                           0.2
  Only PGII \<15      0.80   0.91               0.8               a[](#t5-fn1){ref-type="fn"}               3.3                          1.97                           1.7                           1.2                           0.3
  Only PGII \<19      0.80   0.92               0.9               [a](#t5-fn3){ref-type="fn"}               3.6                           2.2                          1.83                           1.3                           0.3
  Only PGII \<30      0.76   0.94               1.1               [a](#t5-fn3){ref-type="fn"}               4.6                           2.8                           2.3                          1.65                          1.66
  Only PGII \>11.8    0.37   0.98               4.7               [a](#t5-fn3){ref-type="fn"}              19.1                          11.4                           9.6                           6.8                          1.69

Abbreviations: OSCC=oesophageal squamous cell carcinoma; PGI=pepsinogen I; PGII=pepsinogen II.

ORs are adjusted for age, sex, and residence area in unconditional logistic regression model.

These cells yielded negative adjusted counts, which were impossible values for true counts, thus corrected ORs could not be estimated.
